Control group:gemcitabine plus cisplatin

2 trials

Sponsors

Sun Yat-Sen University Cancer center, Eastern Hepatobiliary Surgery Hospital Second, Military Medical University, Shanghai, China

Conditions

biliary tract cancernasopharyngeal carcinoma

Phase 2

A randomized controlled trial of comparison of Sintilimab plus gemcitabine and cisplatin with gemcitabine combined with chemotherapy for patients with biliary tract cancer after palliative resection

Active, not recruitingChiCTR2000036083

Eastern Hepatobiliary Surgery Hospital Second, Military Medical University, Shanghai, Chinabiliary tract cancer

Start: 2020-10-01Updated: 2020-09-07

Phase 3

A randomized, controlled, multi-center clinical trial for albumin-bound paclitaxel plus cisplatin and capecitabine (Nab-TPC) versus gemcitabine plus cisplatin (GP) in patients with metastatic nasopharyngeal carcinoma

RecruitingChiCTR1900027112

Sun Yat-Sen University Cancer centernasopharyngeal carcinoma

Start: 2019-11-01Updated: 2023-05-22

Related Papers

Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial

BMJ2024-06-1914 citations